FDA approves J&J sedation drug device

(Reuters) – U.S. regulators have approved Johnson & Johnson’s Sedasys system to sedate patients during colonoscopies without the need for a physician to monitor delivery of the injectable sedating agent, the company said on Friday. The device injects the patients who have different types of colonoscopy procedures with propofol, a minimal-to-moderate sedation agent widely used in colonoscopy procedures. …